Cobb, L. P., Rickard, A., Herbert, J., Hanna, G., Palmer, G., Siamakpour-Reihani, S., … Secord, A. A. (2018). Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer. In Gynecologic Oncology (Vol. 149, pp. 14–14). Elsevier BV. https://doi.org/10.1016/j.ygyno.2018.04.037

Cobb, L. P., A. Rickard, J. Herbert, G. Hanna, G. Palmer, S. Siamakpour-Reihani, Z. Huang, et al. “Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer.” In Gynecologic Oncology, 149:14–14. Elsevier BV, 2018. https://doi.org/10.1016/j.ygyno.2018.04.037.

Cobb LP, Rickard A, Herbert J, Hanna G, Palmer G, Siamakpour-Reihani S, et al. Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer. In: Gynecologic Oncology. Elsevier BV; 2018. p. 14–14.

Cobb, L. P., et al. “Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer.” Gynecologic Oncology, vol. 149, Elsevier BV, 2018, pp. 14–14. Crossref, doi:10.1016/j.ygyno.2018.04.037.

Cobb LP, Rickard A, Herbert J, Hanna G, Palmer G, Siamakpour-Reihani S, Huang Z, Peters K, Kontos C, Berchuck A, Secord AA. Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer. Gynecologic Oncology. Elsevier BV; 2018. p. 14–14.